<DOC>
	<DOCNO>NCT01429259</DOCNO>
	<brief_summary>This study determine concentration antibiotic meropenem administer 3 hour prolong infusion child cystic fibrosis hospitalize acute pulmonary exacerbation . Safety practicality administer meropenem 3 hour infusion measure .</brief_summary>
	<brief_title>Population Pharmacokinetics Prolonged Infusion Meropenem Cystic Fibrosis ( CF ) Children</brief_title>
	<detailed_description>This study conduct 7 pediatric hospital United States ( Columbia University Medical Center , New York , New York ; University North Carolina , Chapel Hill , North Carolina ; St. Christopher 's Hospital Children , Philadelphia , Pennsylvania , Connecticut Children 's Medical Center , Hartford , Connecticut , Riley Hospital Children , Indianapolis , Indiana , Nationwide Hospital Children , Columbus , Ohio , Children 's Medical Center , Dallas , Texas ) . Cystic Fibrosis child ( age 6-17 year ) admit one enrol site acute exacerbation pulmonary infection require antibiotic therapy meropenem eligible . Meropenem administer 3 hour prolonged infusion blood concentration measure determine population pharmacokinetics 30 patient , safety prolong infusion meropenem , practicality measure treatment burden use questionaire . The population pharmacokinetic model develop utilized determine optimal dose meropenem administer child Cystic Fibrosis , define exposure response relationship drug population .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<criteria>Cystic Fibrosis Hospitalized acute pulmonary exacerbation Caused Pseudomonas aeruginosa bacteria meropenem would appropriate antibiotic treatment Known allergy meropenem Require le 3 day meropenem hospital Require another systemic Betalactam antibiotic treat concomitant pathogen Known fungal viral infection Females 2nd 3rd trimester pregnancy Moderate severe renal dysfunction , define creatinine clearance le 50 ml/min/1.73m2 ( use Schwartz method ) History solid organ transplantation within previous 6 month Active recent ( within 30 day ) participation another antibiotic clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Acute Pulmonary Exacerbations</keyword>
	<keyword>Pseudomonas aeruginosa</keyword>
</DOC>